A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal
|
|||||
|
       
  |
Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections. . . . → Read More: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance 
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial 
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round. . . . → Read More: Synthetic DNA Company Raises $24M in Early Funds 
A smartphone app designed to non-invasively estimate hemoglobin levels is being assessed for its ability to measure anemia in chronic kidney disease patients. . . . → Read More: Mobile App Studied to Measure Kidney Disease Anemia 
Nine universities in the U.S. are taking part in a program supporting research and entrepreneurs developing food and agricultural solutions in rural areas. . . . → Read More: Nine Campuses Join Rural Food Research Fund 
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology 
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease. . . . → Read More: Vaccine Stops Lyme Bacteria in Preclinical Test 
A clinical trial shows two synthetic antibodies given together reduce the risk of symptomatic infections among household members of Covid-19 patients. . . . → Read More: Antibody Cocktail Prevents Covid-19 Disease Symptoms 
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease. . . . → Read More: Arthritis Drug Unsuccessful for Covid-19 Hospital Patients |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
